Cholesterol crystals and IgE-containing immune complexes in rheumatoid pericarditis.

A 72-year-old rheumatoid arthritis patient is described presenting with acute dyspnoea and peripheral oedema. A pericardial effusion with signs of tamponade was diagnosed. Examination of the pericardial fluid revealed the presence of cholesterol crystals and IgE-containing immune complexes. The significance of these findings in the differential diagnosis of pericardial disease is discussed.

Implantation of a dual chamber pacemaker in a patient with persistent left superior vena cava.

A patient underwent dual chamber pacemaker implantation by puncture of the left subclavian vein. During the procedure we observed persistence of the left superior vena cava. A "J-shaped" atrial lead was used for ventricular pacing with excellent long-term results. This technique can be a valuable alternative when confronted with the problem of persistent left superior vena cava during pacemaker implantation.

Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study.

This study compares inducibility of ventricular tachyarrhythmias by programmed electrical stimulation of the heart in patients with myocardial infarction with and without reperfusion after streptokinase therapy. Sixty-two consecutive patients admitted with an acute myocardial infarction were randomized to either combined intravenous and intracoronary streptokinase (streptokinase group) or to standard coronary care unit treatment (control group). Thirty-six of the 62 patients (21 patients from the streptokinase and 15 from the control group) with a first myocardial infarction were studied by programmed ventricular stimulation after a mean of 26 +/- 14 days. No patient had a history of antiarrhythmic drug use or documentation of a ventricular arrhythmia before the initial admission. A sustained ventricular arrhythmia was induced in 10 (48%) of the 21 patients randomized to streptokinase therapy and in all 15 (100%) control patients (p less than 0.001). Sustained monomorphic ventricular tachycardia was induced in 6 (29%) and 10 (67%) patients, respectively (p less than 0.05). To terminate an induced arrhythmia, direct current countershock was required in 33% of patients in the streptokinase group and 73% of patients in the control group (p less than 0.02). Seventeen of the 21 patients treated with streptokinase and no control patient had evidence of early reperfusion 200 +/- 70 minutes after the onset of pain. In comparison with patients without early reperfusion, patients in the reperfused group had a lower maximal serum creatine kinase value (p less than 0.01), a shorter time to peak creatine kinase value (p less than 0.001) and a higher angiographic left ventricular ejection fraction (62 versus 45%, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Is there a universal antitachycardia pacing mode?

A pacing mode using automatically increasing number of stimuli with adaptive coupling intervals was evaluated prospectively as a possible universal pacing mode, because a universal mode would save extensive testing and tailoring time. In group 1, which included 7 patients with implanted antitachycardia pacemaker systems, the test mode was compared with the previously tested and tailored mode. In group 2, which included 11 patients undergoing invasive electrophysiologic study, the test mode was compared with the scanning and asynchronous burst mode. There were 4 patients in group 3. The mode was tested prospectively in these 4 patients. Three of these patients were tested after pacemaker implantation (in supine and upright body position and after moderate exercise). The fourth patient had recurring episodes of VT, which were terminated with the test mode via an external lead. Of 209 tachycardias (156 supraventricular tachycardia [SVT] and 53 with VT) studied with the test mode, 1 episode of nonsustained atrial fibrillation was induced from the ventricle and 1 episode of VT was not terminated using the test mode and long coupling intervals. Two episodes of VT in patients with a recent myocardial infarction (MI) required direct-current countershock: due to acceleration in 1 patient and due to VF in 1. All other tachycardias were terminated promptly by the test mode without prior knowledge about successful coupling intervals or number of stimuli. Of the remaining 106 tachycardias studied (69 SVT, 37 VT) the scanning mode failed to terminate 2 episodes of SVT with up to 4 atrial premature beats and induced acceleration of VT in 1 patient with a recent MI.(ABSTRACT TRUNCATED AT 250 WORDS)

Atrial pacing bigeminy: a manifestation of crosstalk.

Atrial pacing bigeminy, defined as atrial pacing with alternating short and long cycle lengths, was recorded in two out of five DDD-pacemaker implants. Another fascinating feature, the lowering of the effective pacing rate after programming to a higher rate, occurred in one patient. Both phenomena can be explained by crosstalk; appropriate programming resulted in normal DDD-function in all cases. These observations in our patients have led to some interesting conclusions regarding multiprogrammability and nominal settings.

Temporary AVI pacing by chest wall stimulation.

Temporary atrial pacing (coded AVI pacing) has recently been proposed to assess atrial capture in patients with unipolar dual chamber pacemakers. This pacing mode can usually be achieved by programming the ventricular output to a subthreshold value. In patients with noncommitted bifocal pacemakers, AVI pacing can also be obtained by prolonging the programmed AV delay allowing for spontaneous conduction after atrial capture. However, in patients with prolonged AV conduction and a low aventricular stimulation threshold, ventricular stimulation cannot be prevented using the forementioned procedures. Using chest wall stimulation, we developed and tested a new method of temporary AVI pacing in patients with noncommitted DDD or DVI pacemakers.

Temporary A-V sequential pacing using chest wall stimulation.

We describe the therapeutic application of chest wall stimulation enabling temporary A-V sequential pacing in patients with an implanted VVT pacemaker following the transvenous introduction of only one temporary electrode.